Have a feature idea you'd love to see implemented?
Let us know!
NMTC NEUROONE MEDICAL TECHNOLOGIES Corp
Price (delayed)
$0.94
Market cap
$28.96M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.48
Enterprise value
$27.55M
Highlights
The EPS has grown by 21% year-on-year and by 17% since the previous quarter
NEUROONE MEDICAL TECHNOLOGIES's gross profit has shrunk by 69% YoY but it has increased by 3.5% QoQ
NEUROONE MEDICAL TECHNOLOGIES's net income has decreased by 20% YoY but it has increased by 5% from the previous quarter
The company's debt has surged by 136% YoY
The gross margin has shrunk by 63% YoY
Key stats
What are the main financial stats of NMTC
Market
Valuations
Earnings
Shares outstanding
30.81M
Market cap
$28.96M
Enterprise value
$27.55M
Price to earnings (P/E)
N/A
Price to book (P/B)
8.59
Price to sales (P/S)
6.55
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
7.02
Revenue
$3.92M
EBIT
-$12.1M
EBITDA
-$11.74M
Free cash flow
-$11.38M
Per share
Balance sheet
Liquidity
EPS
-$0.48
Free cash flow per share
-$0.42
Book value per share
$0.11
Revenue per share
$0.14
TBVPS
$0.18
Total assets
$4.91M
Total liabilities
$1.9M
Debt
$209,910
Equity
$3.01M
Working capital
$2.39M
Debt to equity
0.07
Current ratio
2.42
Quick ratio
1.2
Net debt/EBITDA
0.12
Margins
Efficiency
Dividend
EBITDA margin
-299.4%
Gross margin
28.9%
Net margin
-308.5%
Operating margin
-311.9%
Return on assets
-199.8%
Return on equity
-276.1%
Return on invested capital
-845.9%
Return on capital employed
-375.7%
Return on sales
-308.5%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
NMTC stock price
How has the NEUROONE MEDICAL TECHNOLOGIES stock price performed over time
Intraday
-5.06%
1 week
-3.09%
1 month
24.36%
1 year
6.67%
YTD
-40.51%
QTD
-5.05%
Financial performance
How have NEUROONE MEDICAL TECHNOLOGIES's revenue and profit performed over time
Revenue
$3.92M
Gross profit
$1.13M
Operating income
-$12.24M
Net income
-$12.1M
Gross margin
28.9%
Net margin
-308.5%
NEUROONE MEDICAL TECHNOLOGIES's gross profit has shrunk by 69% YoY but it has increased by 3.5% QoQ
The gross margin has shrunk by 63% YoY
NMTC's operating margin is down by 43% YoY but it is up by 10% from the previous quarter
The company's net margin fell by 43% YoY but it rose by 10% QoQ
Growth
What is NEUROONE MEDICAL TECHNOLOGIES's growth rate over time
Valuation
What is NEUROONE MEDICAL TECHNOLOGIES stock price valuation
P/E
N/A
P/B
8.59
P/S
6.55
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
7.02
The EPS has grown by 21% year-on-year and by 17% since the previous quarter
The P/B is 26% above the last 4 quarters average of 6.8 and 24% above the 5-year quarterly average of 6.9
NEUROONE MEDICAL TECHNOLOGIES's equity has decreased by 23% YoY and by 22% from the previous quarter
The price to sales (P/S) is 85% lower than the 5-year quarterly average of 42.3 and 18% lower than the last 4 quarters average of 8.0
NMTC's revenue is down by 16% year-on-year but it is up by 5% since the previous quarter
Efficiency
How efficient is NEUROONE MEDICAL TECHNOLOGIES business performance
The return on equity has dropped by 86% year-on-year
NMTC's ROA has plunged by 75% YoY but it is up by 2.2% from the previous quarter
The company's return on invested capital has shrunk by 73% YoY but it rose by 19% QoQ
The ROS has declined by 43% year-on-year but it has grown by 10% since the previous quarter
Dividends
What is NMTC's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for NMTC.
Financial health
How did NEUROONE MEDICAL TECHNOLOGIES financials performed over time
The total assets is 158% greater than the total liabilities
The quick ratio is down by 38% QoQ and by 32% YoY
NMTC's total liabilities is up by 23% from the previous quarter and by 3.5% YoY
The company's debt is 93% lower than its equity
The company's debt has surged by 136% YoY
NEUROONE MEDICAL TECHNOLOGIES's equity has decreased by 23% YoY and by 22% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.